Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20268 Citations
Octreotide is an FDA-approved somatostatin analog with three labeled indications and 35+ years of clinical data. The PROMID trial showed it doubled time to tumor progression in midgut NETs. Near-complete subcutaneous bioavailability, but gallstones affect up to 65% of long-term users. Supplied as a pre-filled solution.
50mcg · 3x Daily
Summary: Add 0mL BAC water to your 0.05mg vial. Draw to < 0.1 units on a U-100 syringe for a 50mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50mcg | 3x Daily |
| Moderate | 100mcg | 3x Daily |
| Aggressive | 200mcg | 3x Daily |
Octreotide SC comes as a pre-filled solution. No reconstitution with bacteriostatic water needed, which makes this easier than most injectable peptides. The common vial concentrations are 50, 100, 200, and 500 mcg/mL. Check the label every single time before drawing your dose. The difference between a 50 mcg/mL vial and a 500 mcg/mL vial is a tenfold dosing error waiting to happen. For the 100 mcg/mL vial: drawing 0.5 mL gives you 50 mcg; 1.0 mL gives you 100 mcg. On a U-100 insulin syringe, 50 units equals 50 mcg from a 100 mcg/mL vial. Allow the solution to reach room temperature before injecting. Cold solution stings noticeably more. Rotate between abdomen and thigh injection sites. The thing most beginners miss: GI side effects are worst when you inject on an empty stomach. Timing your SC doses with meals or just before eating reduces diarrhea and cramping significantly. Patients who don't learn this trick early tend to have a rougher first month than necessary. Store opened vials refrigerated at 2 to 8 degrees Celsius. Stable at room temperature for up to 14 days if kept away from light.
Dosing based on Sandostatin (octreotide acetate) FDA Prescribing Information (2022) — 11 published references.View all sources →
Cross-check your Octreotide (Sandostatin) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Octreotide is an FDA-approved somatostatin analog with three labeled indications and 35+ years of clinical data. The PROMID trial showed it doubled time to tumor progression in midgut NETs. Near-complete subcutaneous bioavailability, but gallstones affect up to 65% of long-term users. Supplied as a pre-filled solution.